Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06004063 · ClinicalTrials.gov registry record · NA
Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study
A NA study of Stem Cell, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT06004063: Active NA study of Stem Cell, sponsored by M.D. Anderson Cancer Center.
NCT06004063 is a NA study of Stem Cell that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06004063, a NA study of Stem Cell, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Enteral nutrition (EN)
- OTHER Standard care parenteral nutrition (PN)
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What the registry record for NCT06004063 still lists
NCT06004063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Stem Cell appearing as the primary indexed condition, and to 2 interventions - of which Enteral nutrition (EN) is the first listed.
NCT06004063 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06004063 about?
NCT06004063 is a clinical study titled "Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study". The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.
What is the current status of trial NCT06004063?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3 participants. The study started on 2023-08-04. Estimated completion is 2029-12-31.
What conditions does trial NCT06004063 study?
This clinical trial studies the following conditions: Stem Cell.
What interventions are being tested in trial NCT06004063?
The interventions under investigation include: Enteral nutrition (EN) (DIETARY_SUPPLEMENT), Standard care parenteral nutrition (PN) (OTHER).
Who is sponsoring clinical trial NCT06004063?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06004063 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06004063's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI